Concepedia

Author

Catherine Weiss

Lundbeck (Denmark)ORCID

Also Known As

C WEISS, C. Weiss, C.J. Weiss, Catherine Weiss, Catherine Weiss, PhD, Weiss, Catherine

60

Publications

643

Citations

16

H-Index

19

Concepts

All Affiliations

Lundbeck (Denmark)Otsuka (United States)University of TorontoUniversity of PennsylvaniaUniversity Health Network
CW

About

Catherine Weiss is an author at Lundbeck (Denmark) specializing in psychopharmacology, depression, and psychopathology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

78

2

Social Sciences

3

3

78

3

Pharmacology

3

3

78

4

Psychiatry

3

3

78

5

Psychology

1

1

33

Catherine Weiss

×

17

Publications

359

Citations

12

H-Index

YearCitations

The impact on functioning of second-generation antipsychotic medication side effects for patients with schizophrenia: a worldwide, cross-sectional, web-based survey

Rajiv Tandon, William R. Lenderking, Catherine Weiss,

Annals of General Psychiatry

2020

65

Brexpiprazole as adjunctive treatment of major depressive disorder with anxious distress: Results from a post-hoc analysis of two randomised controlled trials

Roger S. McIntyre, Emmanuelle Weiller, Peter Zhang,

Journal of Affective Disorders

2016

33

Brexpiprazole in patients with schizophrenia: overview of short- and long-term phase 3 controlled studies

Stephen R. Marder, Mika Hakala, Mette Krog Josiassen,

Acta Neuropsychiatrica

2016

33

Adjunctive brexpiprazole in patients with major depressive disorder and anxiety symptoms: post hoc analyses of three placebo-controlled studies

Michael E. Thase, Emmanuelle Weiller, Peter Zhang,

Neuropsychiatric Disease and Treatment

2018

25

The effects of brexpiprazole and aripiprazole on body weight as monotherapy in patients with schizophrenia and as adjunctive treatment in patients with major depressive disorder

Catherine Weiss, Emmanuelle Weiller, Ross A. Baker,

International Clinical Psychopharmacology

2018

25

Understanding the emotions of patients with inadequate response to antidepressant treatments: results of an international online survey in patients with major depressive disorder

Rajnish Mago, Andrea Fagiolini, Emmanuelle Weiller,

BMC Psychiatry

2018

23

Overview of Short-Term and Long-Term Safety of Brexpiprazole in Patients with Major Depressive Disorder and Inadequate Response to Antidepressant Treatment

J. Craig Nelson, Peter Zhang, Aleksandar Skuban,

Current Psychiatry Reviews

2016

20

Adjunctive Brexpiprazole and Functioning in Major Depressive Disorder: A Pooled Analysis of Six Randomized Studies Using the Sheehan Disability Scale

Mary Hobart, Peter Zhang, Catherine Weiss,

The International Journal of Neuropsychopharmacology

2018

20

Effects of adjunctive brexpiprazole on calmness and life engagement in major depressive disorder: post hoc analysis of patient-reported outcomes from clinical trial exit interviews

Catherine Weiss, Stine R. Meehan, T. Michelle Brown,

Journal of Patient-Reported Outcomes

2021

19

Efficacy of adjunctive brexpiprazole on the core symptoms of major depressive disorder: A post hoc analysis of two pooled clinical studies

J. Craig Nelson, Emmanuelle Weiller, Peter Zhang,

Journal of Affective Disorders

2017

17

Page 1